Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Horizon Kinetics Medical ETF (MEDX)

Horizon Kinetics Medical ETF (MEDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Horizon Kinetics
  • Assets Under Management 18,679,100
  • Shares Outstanding, K 570
  • 60-Month Beta 0.62
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.507 on 12/24/24
  • Management Fee 0.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.67 +3.47%
on 11/10/25
34.09 -3.88%
on 11/26/25
+1.35 (+4.28%)
since 11/07/25
3-Month
28.87 +13.53%
on 09/25/25
34.09 -3.88%
on 11/26/25
+3.29 (+11.17%)
since 09/09/25
52-Week
23.46 +39.69%
on 04/09/25
34.09 -3.88%
on 11/26/25
+4.26 (+14.92%)
since 12/09/24

Most Recent Stories

More News
Horizon Kinetics Announces Upcoming Horizon Kinetics Active ETF Portfolio Manager Webinar Series

NEW YORK, NY, AL / ACCESS Newswire / October 21, 2025 / Horizon Kinetics is pleased to announce the launch of its 2025 Horizon Kinetics Active ETF Portfolio Manager Webinar Series, practicing the firm's...

NVIR : 33.47 (-0.14%)
JAPN : 25.55 (-0.76%)
MEDX : 32.77 (-1.33%)
INFL : 44.69 (+0.54%)
SPAQ : 106.89 (unch)
BCDF : 31.19 (+1.09%)
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data

Eli Lilly and Company LLY reported robust second-quarter 2025 results, wherein it beat estimates on both the top and bottom lines, driven by strong demand for its blockbuster weight loss and diabetes drugs....

NVO : 46.36 (-0.88%)
OZEM : 33.32 (-2.25%)
IHE : 81.99 (-1.35%)
LLY : 982.22 (-1.54%)
MEDX : 32.77 (-1.33%)
PPH : 97.57 (-1.12%)
MEDI : 30.66 (-2.03%)
Novartis Gets Retail Chatting After Upbeat Q4, But Sentiment Stays Tepid Amid Volatile Trading

The company is facing upcoming patent expirations for three key drugs, with Entresto expected to face generic competition in the U.S. mid-year.

DIVD : 37.93 (-0.17%)
MEDX : 32.77 (-1.33%)
NVS : 131.01 (+0.65%)
AVIV : 70.16 (-0.01%)
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip

Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss medicine...

OZEM : 33.32 (-2.25%)
IHE : 81.99 (-1.35%)
LLY : 982.22 (-1.54%)
MEDX : 32.77 (-1.33%)
PPH : 97.57 (-1.12%)
THNR : 24.68 (-1.13%)
Are Wall Street Analysts Bullish on Amgen Stock?

Amgen has outperformed the broader market over the past year, yet Wall Street analysts remain cautiously optimistic about the stock’s prospects.

$SPX : 6,840.51 (-0.09%)
MEDX : 32.77 (-1.33%)
AMGN : 313.85 (-2.30%)
Horizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX)

NEW YORK, NY / ACCESSWIRE / January 30, 2023 / Horizon Kinetics LLC today launched the Horizon Kinetics SPAC Active ETF (NASDAQ:SPAQ) and the Horizon Kinetics Medical ETF (NASDAQ:MEDX). SPAQ was converted...

MEDX : 32.77 (-1.33%)
SPAQ : 106.89 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Fund Summary

The Horizon Kinetics Medical ETF seeks long-term growth of capital.

See More

Key Turning Points

3rd Resistance Point 33.42
2nd Resistance Point 33.29
1st Resistance Point 33.03
Last Price 32.77
1st Support Level 32.64
2nd Support Level 32.51
3rd Support Level 32.25

See More

52-Week High 34.09
Last Price 32.77
Fibonacci 61.8% 30.03
Fibonacci 50% 28.78
Fibonacci 38.2% 27.52
52-Week Low 23.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar